Satellos Bioscience Doses First Adult Patient in LT-001, a Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystroph Toronto, Ontario — [Insert Date], 2025 — Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company…
Merck Presents Systematic Review of Pneumococcal Serotypes Covered by CAPVAXIVE® in U.S. Adults Merck & Co., Inc., known as MSD outside the United States and Canada, announced findings from a systematic literature review on the epidemiology and antimicrobial resistance (AMR)…
Samsung Bioepis and Phrontline Biopharma Enter Global Collaboration to Advance Next-Generation Antibody-Drug Conjugates for Solid Tumors Samsung Bioepis Co., Ltd., a leading global biopharmaceutical company, and Phrontline Biopharma, a clinical-stage biotechnology firm pioneering a new generation of Antibody-Drug Conjugates (ADCs),…
IFF and BASF Launch Strategic Collaboration to Advance Next-Generation Enzyme and Polymer Technologies International Flavors & Fragrances Inc. (IFF), a global leader in flavors, fragrances, food ingredients, health, and biosciences, has announced a strategic collaboration with BASF, one of the…
StratifAI Selected for MSK iHub Challenge 2025 Cohort to Accelerate Polaris™ Validation Using World-Class Clinical Datasets StratifAI, the AI-driven precision oncology company behind the Polaris™ platform, today announced its selection for the prestigious Memorial Sloan Kettering (MSK) iHub Challenge 2025…
Atom Therapeutics to Present Positive Clinical Trial Data for Lead Gout Therapies at ACR Convergence 2025 Atom Therapeutics, a clinical-stage biotechnology company focused on developing innovative treatments for inflammatory and metabolic diseases, announced today that it will present two abstracts…
Ferrer Completes Recruitment for PROSPER Phase II Trial in Progressive Supranuclear Palsy Ahead of Schedule Spanish multinational pharmaceutical company Ferrer has announced the successful completion of patient recruitment for the PROSPER study, a Phase II clinical trial investigating FNP-223, a…
Rigaku Establishes Technology Center in Taiwan to Strengthen R&D and Customer Support Rigaku Holdings Corporation, headquartered in Akishima, Tokyo, and led by CEO Jun Kawakami, has announced the establishment of Rigaku Technology Taiwan Co., Ltd. (RTTW), a new group company…
Enamine Plays Key Role in Discovery of Promising Broad-Spectrum Coronavirus Antiviral Enamine, a leading chemistry and R&D services company, has announced its pivotal contribution to the discovery of a promising broad-spectrum coronavirus antiviral pre-clinical candidate. This milestone was achieved through…
IonQ Achieves Record-Breaking Quantum Computing Performance, Surpasses 99.99% Two-Qubit Gate Fidelity IonQ (NYSE: IONQ), a global leader in quantum computing, today announced a historic milestone in quantum technology: the company has achieved 99.99% two-qubit gate fidelity, setting a new world…